Top Page
Delorean Corporation Ltd
(Sydney:DEL)
Delorean Corporation Ltd (DEL) vs. iShares MSCI Australia ETF (EWA)
Delorean Corporation Ltd Business Overview & Revenue Model
Delorean Corporation Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.83M | 19.83M | 27.88M | 19.25M | 39.33M | 27.88M |
| Gross Profit | -2.99M | -2.99M | 7.83M | -7.18M | -6.77M | -342.89K |
| EBITDA | -6.13M | -6.13M | 5.04M | -9.06M | -11.87M | -4.08M |
| Net Income | -6.55M | -6.55M | 4.77M | -10.02M | -10.89M | -3.21M |
Balance Sheet | ||||||
| Total Assets | 48.30M | 48.30M | 28.05M | 17.92M | 24.10M | 28.77M |
| Cash, Cash Equivalents and Short-Term Investments | 10.66M | 10.66M | 8.84M | 1.00M | 3.12M | 13.07M |
| Total Debt | 31.31M | 31.31M | 9.07M | 7.62M | 2.63M | 2.78M |
| Total Liabilities | 40.45M | 40.45M | 19.28M | 15.75M | 12.21M | 12.50M |
| Stockholders Equity | 7.85M | 7.85M | 8.77M | 2.17M | 11.88M | 16.27M |
Cash Flow | ||||||
| Free Cash Flow | -21.50M | -21.50M | 6.89M | -6.80M | -15.21M | -2.59M |
| Operating Cash Flow | -5.66M | -5.66M | 7.24M | -5.36M | -11.77M | 156.59K |
| Investing Cash Flow | -15.08M | -15.08M | -3.92M | -1.44M | -3.44M | -4.49M |
| Financing Cash Flow | 23.33M | 23.33M | 915.22K | 4.68M | 5.26M | 14.49M |
Delorean Corporation Ltd Technical Analysis
Delorean Corporation Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | AU$16.61M | 18.24 | 14.11% | ― | -11.85% | 6.25% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
47 Neutral | AU$32.21M | -12.34 | -11.34% | ― | -8.52% | 13.51% | |
45 Neutral | AU$19.93M | 6.28 | -38.32% | ― | 2.69% | -273.87% | |
44 Neutral | AU$31.94M | -3.56 | -129.44% | ― | -29.97% | -284.16% | |
34 Underperform | AU$19.89M | ― | -84.32% | ― | ― | 91.54% | |
26 Underperform | AU$13.90M | ― | -47.12% | ― | ― | -15.24% |
Delorean Corporation Ltd Corporate Events
Delorean Corporation Ltd has announced the completion of construction for the Yarra Valley Water Lilydale bioenergy facility in Victoria. The facility, which processes 55,000 tonnes of organic waste annually, will generate renewable electricity and reduce CO₂ emissions significantly. The completion marks the start of the Operations & Maintenance phase, valued at $8 million over two and a half years, enhancing Delorean’s operational footprint in the renewable energy sector.
Delorean Corporation Ltd has successfully received a $2.7 million grant payment from the Australian Renewable Energy Agency (ARENA) as part of a $6.08 million funding agreement. This payment supports the development of Delorean’s SA1 Salisbury bioenergy facility in South Australia, which aims to produce mains-grade biomethane for industrial use. The project has achieved significant construction milestones, including the completion of tank farm slabs and the commencement of digester tank construction, keeping it on track to deliver renewable gas and long-term benefits to the South Australian industry.
Delorean Corporation Ltd has announced a reduction in profit due to delays in the grid connection of its Yarra Valley Water DBOM contract. Despite these delays, the company remains confident in the project’s financial success, as the contract’s operational and maintenance phases are expected to offset initial profit reductions. The company also confirmed compliance with ASX Listing Rules and highlighted that the financial impact was only finalized with the release of its Preliminary Final Report.
Delorean Corporation Limited has released its Annual Report for 2025, highlighting its focus on bioenergy and renewable energy sectors. The report outlines the company’s financial performance, strategic initiatives, and future outlook, emphasizing its commitment to sustainability and innovation in the energy industry.
Delorean Corporation Limited has announced adjustments to its financial statements for the year ending June 30, 2025, as reflected in its Annual Report. The adjustments include a decrease in revenue due to higher project costs, changes in depreciation and finance costs, and an increase in income tax expense due to the reversal of deferred tax assets. Additionally, there were changes in financial position, including a reclassification of borrowings and adjustments in contract liabilities and reserves. These changes highlight the company’s financial recalibrations and their implications for stakeholders.
Delorean Corporation Ltd has secured a $14.5 million bank loan facility from National Australia Bank to support the construction of its SA1 Salisbury Bioenergy Project in South Australia. This funding milestone marks Delorean’s first engagement with a major Australian bank, potentially paving the way for broader financing opportunities across its clean energy infrastructure portfolio. The loan will refinance part of Delorean’s existing corporate finance package at a lower cost, allowing the company to redirect funds towards other bioenergy projects. This strategic move is expected to accelerate the rollout of Delorean’s renewable gas projects, aligning with the increasing demand for renewable energy in Australia.
Delorean Corporation Limited has announced the issuance of 5,218,602 performance rights expiring on July 31, 2029, as part of an employee incentive scheme. These securities are unquoted and not intended to be listed on the ASX, indicating a strategic move to motivate and retain key personnel, potentially impacting the company’s operational efficiency and stakeholder engagement.
Delorean Corporation Ltd has secured a long-term Gas Sales Agreement with Origin Energy for the supply of renewable biomethane from its SA1 Salisbury bioenergy facility, expected to commence in April 2026. This agreement, which is part of a broader strategy involving multiple revenue streams, ensures significant revenue over the next decade and supports Delorean’s future bioenergy projects, enhancing its industry positioning and stakeholder confidence.
Delorean Corporation Ltd has announced the appointment of Surena Mei Wein Ho as a director effective from August 1, 2025. The initial director’s interest notice reveals that Surena Mei Wein Ho currently holds no securities or interests in contracts related to the company. This appointment is part of Delorean Corporation’s ongoing efforts to strengthen its leadership team, although the new director does not hold any financial interests in the company at this time.
Delorean Corporation Limited has announced the cessation of David McArthur as a director, effective August 1, 2025. This update is part of the company’s compliance with ASX listing rules, specifically regarding the disclosure of directors’ interests in securities. The announcement indicates that McArthur held 476,470 fully paid ordinary shares as a registered holder, with no additional interests in securities or contracts. This change in directorship may impact the company’s governance structure, but no immediate implications for stakeholders have been detailed.
Delorean Corporation Limited reported significant progress in its renewable energy projects for the quarter ending June 2025, marking a pivotal year with a shift towards renewable gas production. Key developments include the completion of major construction milestones at the Yarra Valley Water Food Waste to Energy project and advancements in the SA1 Salisbury Bioenergy facility. The company is well-positioned to benefit from recent regulatory reforms recognizing biomethane as a natural gas equivalent, which could provide new revenue streams and reduce investment risks.